Increased Risk of Thyroid Eye Disease Following Covid-19 Vaccination

Area of Science:

• Endocrinology
• Immunology
• Ophthalmology

Background:

• SARS-CoV-2 infection and COVID-19 vaccines are associated with various thyroid disorders.
• Thyroid eye disease (TED) is an autoimmune condition affecting the eyes, often linked to Graves' disease.

Purpose of the Study:

• To analyze the risk of developing or reactivating thyroid eye disease (TED) following COVID-19 vaccination.
• To investigate the temporal relationship between COVID-19 vaccination and TED onset.

Main Methods:

• A self-controlled case series study involving 98 patients with newly developed or reactivated TED.
• Analysis of person-days, defining exposed periods as 1-28 days post-vaccination and unexposed periods as outside this window.
• Conditional Poisson regression models were used to calculate incidence rate ratios (IRR) and 95% confidence intervals (CI).

Main Results:

• An increased risk of TED was observed following COVID-19 vaccination, with an IRR of 3.24 (95% CI 2.01-5.20).
• The risk was significantly higher in patients below 50 years of age (IRR 4.70, 95% CI 2.39-9.23).
• TED risk did not differ based on sex, smoking status, or radioiodine treatment, and decreased over time post-vaccination.

Conclusions:

• COVID-19 vaccination is associated with a significantly increased risk of thyroid eye disease (TED).
• The risk is particularly elevated in younger individuals (<50 years).
• Potential mechanisms involve spike protein interactions and immune responses; monitoring is recommended for at-risk populations.